Fovea Pharmaceuticals
Records under this name other than the patents Fovea Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Fovea Pharmaceuticals
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,107,928 | Compositions and Methods for Treating Ophthalmic Disorders Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,249,085 | Aniline Derivatives, Their Preparation and Their Therapeutic Application Formerly held In force · High confidence | In force | High confidence | |
| US 9,624,159 | Aniline Derivatives, Their Preparation and Their Therapeutic Application Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,808,242 | Apparatus for Injection into an Eye Lapsed on the fee record Ended Aug 19, 2026 · High confidence | Lapsed on the fee record | Ended Aug 19, 2026 | High confidence |
| US 8,460,242 | Apparatus for intra-ocular injection Lapsed on the fee record Ended Jun 11, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2021 | From the USPTO record |
| US 8,389,530 | Substituted quinazoline compounds Lapsed on the fee record Ended Mar 5, 2017 · From the USPTO record | Lapsed on the fee record | Ended Mar 5, 2017 | From the USPTO record |